C-reactive protein level as a predictor of mortality in liver disease patients with bacteremia

References

• Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med 1966;123:365–78.
   PubMed Web of Science ®Google Scholar
• Kushner I, Feldmann G. Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit. J Exp Med 1978;148:466–77.
   PubMed Web of Science ®Google Scholar
• Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSf-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Letters 1988;232:347–50.
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I, Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.
   Google Scholar
• Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002;28:235–43.
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17.
   PubMed Web of Science ®Google Scholar
• Gradel KO, Thomsen RW, Lundbye-Christensen S, Nielsen H, Schønheyder HC. Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study. Clin Microbiol Infect 2011;17;627–32.
   PubMedGoogle Scholar
• Le Moine O, Deviere J, Devaster JM, Crusiaux A, Durand F, Bernuau J, Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 1994;20:819–24.
   PubMed Web of Science ®Google Scholar
• Park WB, Lee KD, Lee CS, Jang HC, Kim HB, Lee HS, Production of C-reactive protein in Eschericia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 2005;51:227–30.
   PubMedGoogle Scholar
• Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intensive Care Med 2006;32:1344–51.
   PubMedGoogle Scholar
• Bota DF, Nuffelen MV, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005;146:347–51.
   PubMed Web of Science ®Google Scholar
• Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Thulstrup AM, Sørensen HT, Schønheyder HC, Møller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 2000;31:1357–61.
   PubMed Web of Science ®Google Scholar
• Linderoth G, Jepsen P, Schønheyder HC, Johnsen SP, Sørensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study. Alcoholism Clin Exp Res 2006;30:636–41.
   PubMedGoogle Scholar
• Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL, Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis 2009;64:124–30.
   PubMed Web of Science ®Google Scholar
• Suffredini AF, Hochstein HD, McMahon FG. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 1999;179:1278–82.
   PubMedGoogle Scholar
• Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med 2000:26:1232–8.
   PubMed Web of Science ®Google Scholar
• Silvestre JPDS, Coelho LMDC, Povoa PMSR. Impact of fulminant hepatic failure in C-reactive protein? J Crit Care 2010;25:657.e7–657.e12.
   Google Scholar
• Spahr L, Morard I, Hadengue A, Vadas L, Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosid. Hepatogastroenterology 2001;48:502–5.
   PubMedGoogle Scholar
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379–86.
   PubMed Web of Science ®Google Scholar
• Vestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst 1997;21:11–20.
   PubMedGoogle Scholar